Literature DB >> 24846097

Best evidence topic reports. BET 3: Topical intranasal tranexamic acid for spontaneous epistaxis.

Lee Hilton, Adam Reuben.   

Abstract

A short-cut review was carried out to establish whether topical tranexamic acid can be used to treat spontaneous epistaxis. Thirty-three papers were found, of which two presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these best papers are tabulated. The clinical bottom line is that there is insufficient evidence to support the use of topical intranasal tranexamic acid in the management of spontaneous epistaxis in haemodynamically stable patients presenting to the emergency department. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  emergency care systems

Mesh:

Substances:

Year:  2014        PMID: 24846097     DOI: 10.1136/emermed-2014-203763.3

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  2 in total

Review 1.  Changing Trends in the Management of Epistaxis.

Authors:  Henri Traboulsi; Elie Alam; Usamah Hadi
Journal:  Int J Otolaryngol       Date:  2015-08-16

2.  Novel use of tranexamic acid to reduce the need for Nasal Packing in Epistaxis (NoPac) randomised controlled trial: research protocol.

Authors:  Adam Reuben; Andrew Appelboam; Andy Barton; Patricia Jane Vickery; Richard Body; Malcolm Hilton; Jason Coppell; Paul Ewings
Journal:  BMJ Open       Date:  2019-02-15       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.